Lys Therapeutics
PrivateLast Round
VC Round
Jun 22, 2026
Total Funding Raised
$15.85M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Lys Therapeutics operates in Healthcare & Life Sciences and is based in Lyon. Its latest recorded funding round was a Grant round in September 2025.
Lys Therapeutics is a biotechnology company developing first-in-class monoclonal antibodies to treat patients with severe neurodegenerative and neurovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lys Therapeutics Comparables
Compare Lys Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neuvasq Biotechnologies | 81% | |
| Axoltis Pharma | 80% | |
| Phragma Therapeutics | 79% |
For institutional investors. Book with your work email.
Lys Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 22, 2026 | ||||
| Grant | Sep 22, 2025 | ||||
| Grant | Sep 24, 2024 | ||||
| Grant | Nov 14, 2023 | ||||
| Seed | Nov 14, 2022 | ||||
Grant | Oct 15, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Lys Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| France 2030 | Grant, VC Round |
| Ministry of Higher Education and Research | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant, VC Round |
| Normandie Participations | VC Round |
| Bpifrance | Grant, Seed, VC Round |
| Zcube | Seed, VC Round |
| TCD Capital | VC Round |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 273% MoM.
- Jul 25, 2026
Monthly visitors grew 101% MoM.
For institutional investors. Book with your work email.
Lys Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lys Therapeutics's valuation, stock price, and market status.
Is Lys Therapeutics a public or private company?
Lys Therapeutics is a private company.
What is the current stock price of Lys Therapeutics?
Lys Therapeutics is a private company, so its shares have no public market price. Caplight tracks Lys Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lys Therapeutics worth (valuation)?
Valuation information for Lys Therapeutics is not publicly available.
Can I buy Lys Therapeutics stock?
Lys Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lys Therapeutics's last funding round?
Lys Therapeutics's most recent funding round was VC Round on June 22, 2026.
Who are the main investors in Lys Therapeutics?
Key investors in Lys Therapeutics include Health Technology Holding.
Will Lys Therapeutics IPO soon?
No public IPO plans have been announced for Lys Therapeutics.
How can I track Lys Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Lys Therapeutics's shares on secondary markets.